Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment | Zendy

Ioannis E. Messinis | Zendy; D. Loutradis | Zendy; Ekaterini Domali | Zendy; C. P. Kotsovassilis | Zendy; L. Papastergiopoulou | Zendy; A. Kallitsaris | Zendy; Peter Drakakis | Zendy; Konstantinos Dafopoulos | Zendy; S. Milingos | Zendy

Open Access

Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment

Author(s) -

Ioannis E. Messinis,

D. Loutradis,

Ekaterini Domali,

C. P. Kotsovassilis,

L. Papastergiopoulou,

A. Kallitsaris,

Peter Drakakis,

Konstantinos Dafopoulos,

S. Milingos

Publication year - 2005

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dei210

Subject(s) - antagonist , gonadotropin releasing hormone antagonist , ovulation , medicine , endocrinology , hormone antagonist , stimulation , gonadotropin , pregnancy rate , pregnancy , andrology , biology , gonadotropin releasing hormone , hormone , luteinizing hormone , receptor , genetics

This randomized controlled trial was designed to evaluate whether a GnRH antagonist given every other day could prevent premature luteinization in women undergoing IVF/ICSI treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research